Transenterix Stock Price, News & Analysis (NYSEAMERICAN:TRXC)

$1.40 0.00 (0.00 %)
(As of 02/19/2018 09:19 AM ET)
Previous Close$1.40
Today's Range$1.36 - $1.42
52-Week Range$0.45 - $5.00
Volume1.76 million shs
Average Volume2.37 million shs
Market Capitalization$278.94 million
P/E Ratio-2.26
Dividend YieldN/A
Beta2.2

About Transenterix (NYSEAMERICAN:TRXC)

Transenterix logoTransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Receive TRXC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRXC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical Equipment, Supplies & Distribution - NEC
SymbolNYSEAMERICAN:TRXC
CUSIPN/A
Phone+1-919-7658400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-2.25806451612903
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.62)
Net IncomeN/A
Net Margins-21,045.36%
Return on Equity-137.69%
Return on Assets-83.60%

Miscellaneous

EmployeesN/A
Outstanding Shares199,500,000

Transenterix (NYSEAMERICAN:TRXC) Frequently Asked Questions

What is Transenterix's stock symbol?

Transenterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."

How were Transenterix's earnings last quarter?

Transenterix Inc (NYSEAMERICAN:TRXC) issued its quarterly earnings results on Monday, March, 6th. The medical instruments supplier reported ($0.12) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.01. Transenterix had a negative return on equity of 137.69% and a negative net margin of 21,045.36%. View Transenterix's Earnings History.

Where is Transenterix's stock going? Where will Transenterix's stock price be in 2018?

4 brokers have issued twelve-month price targets for Transenterix's shares. Their predictions range from $0.70 to $5.00. On average, they anticipate Transenterix's stock price to reach $3.23 in the next twelve months. View Analyst Ratings for Transenterix.

Are investors shorting Transenterix?

Transenterix saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 17,250,155 shares, an increase of 6.5% from the January 12th total of 16,200,995 shares. Based on an average daily volume of 2,000,529 shares, the short-interest ratio is currently 8.6 days. Approximately 11.7% of the shares of the company are sold short.

Who are some of Transenterix's key competitors?

Who are Transenterix's key executives?

Transenterix's management team includes the folowing people:

  • Paul A. LaViolette, Independent Chairman of the Board (Age 58)
  • Todd M. Pope, President, Chief Executive Officer, Director (Age 49)
  • Joseph P. Slattery CPA, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 50)
  • Anthony Fernando, Chief Operating Officer
  • Andrea Biffi, Director
  • Dennis J. Dougherty, Independent Director (Age 56)
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • William N. Kelley M.D., Independent Director (Age 77)
  • Aftab R. Kherani M.D., Independent Director (Age 41)

Who owns Transenterix stock?

Transenterix's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Aisling Capital LLC (4.96%), Redmile Group LLC (2.52%), Masters Capital Management LLC (1.94%), BlackRock Inc. (0.88%), EAM Investors LLC (0.35%) and Millennium Management LLC (0.11%). Company insiders that own Transenterix stock include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar, Todd Pope and Willam N Kelley. View Institutional Ownership Trends for Transenterix.

Who sold Transenterix stock? Who is selling Transenterix stock?

Transenterix's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Aisling Capital LLC and Masters Capital Management LLC. Company insiders that have sold Transenterix company stock in the last year include Joseph P Slattery and Todd Pope. View Insider Buying and Selling for Transenterix.

Who bought Transenterix stock? Who is buying Transenterix stock?

Transenterix's stock was acquired by a variety of institutional investors in the last quarter, including Redmile Group LLC, BlackRock Inc., EAM Investors LLC, LPL Financial LLC, Iguana Healthcare Management LLC, Raymond James Financial Services Advisors Inc., Bank of New York Mellon Corp and Virtu Financial LLC. Company insiders that have bought Transenterix stock in the last two years include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar and Willam N Kelley. View Insider Buying and Selling for Transenterix.

How do I buy Transenterix stock?

Shares of Transenterix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transenterix's stock price today?

One share of Transenterix stock can currently be purchased for approximately $1.40.

How big of a company is Transenterix?

Transenterix has a market capitalization of $278.94 million.

How can I contact Transenterix?

Transenterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400.


MarketBeat Community Rating for Transenterix (TRXC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  148 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  287
MarketBeat's community ratings are surveys of what our community members think about Transenterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Transenterix (NYSEAMERICAN:TRXC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.502.502.672.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.23$3.23$3.23$0.70
Price Target Upside: 39.97% upside39.97% upside12.66% upside31.85% upside

Transenterix (NYSEAMERICAN:TRXC) Consensus Price Target History

Price Target History for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN:TRXC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
12/18/2017BTIG ResearchReiterated RatingHoldView Rating Details
10/31/2017Stifel NicolausBoost Price TargetBuy$3.75 -> $4.00View Rating Details
10/20/2017Ladenburg Thalmann Financial ServicesSet Price TargetBuy$5.00View Rating Details
5/16/2017B. RileyDowngradeNeutral$0.70View Rating Details
1/19/2017Raymond James FinancialDowngradeOutperform -> Mkt PerformView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details
5/11/2016Lake Street CapitalDowngradeBuy -> Hold$2.00View Rating Details
(Data available from 2/19/2016 forward)

Earnings

Transenterix (NYSEAMERICAN:TRXC) Earnings History and Estimates Chart

Earnings by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN TRXC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.09)($0.09)ViewN/AView Earnings Details
8/2/2017Q2 2017($0.11)($0.11)ViewN/AView Earnings Details
5/10/2017Q1 2017($0.12)($0.13)ViewN/AView Earnings Details
3/6/2017Q4 2016($0.11)($0.12)ViewListenView Earnings Details
11/9/2016Q316($0.10)($0.11)$1.80 million$1.50 millionViewListenView Earnings Details
8/5/2016Q2 2016($0.13)($0.11)ViewN/AView Earnings Details
5/10/2016Q116($0.13)($0.12)ViewListenView Earnings Details
3/3/2016Q415($0.12)($0.13)ViewN/AView Earnings Details
11/9/2015Q3 2015($0.11)($0.11)ViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.14)ViewN/AView Earnings Details
5/6/2015Q115($0.17)($0.16)$0.03 millionViewN/AView Earnings Details
2/24/2015Q414($0.18)($0.13)$50.00 million$0.13 millionViewN/AView Earnings Details
11/6/2014Q3($0.18)($0.18)$0.10 million$0.06 millionViewN/AView Earnings Details
8/6/2014Q2 2014($0.13)($0.18)ViewN/AView Earnings Details
5/7/2014($0.14)($0.15)ViewN/AView Earnings Details
3/5/2014Q4 2013($0.20)ViewN/AView Earnings Details
11/12/2013Q3 2013($0.60)ViewN/AView Earnings Details
8/14/2013Q2 2013($0.10)ViewN/AView Earnings Details
5/15/2013Q1 2013($0.05)ViewN/AView Earnings Details
4/1/2013Q4 2012($0.15)ViewN/AView Earnings Details
11/14/2012Q3 2012($0.15)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.20)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.28)ViewN/AView Earnings Details
3/30/2012Q4 2011($0.28)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.27)ViewN/AView Earnings Details
8/12/2011Q2 2011($0.24)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.24)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Transenterix (NYSEAMERICAN:TRXC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Transenterix (NYSEAMERICAN:TRXC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Transenterix (NYSEAMERICAN TRXC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Transenterix (NYSEAMERICAN:TRXC)
Institutional Ownership by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN TRXC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2017Joseph P SlatteryCFOSell529,609$2.80$1,482,905.20440,974View SEC Filing  
11/14/2017Joseph P SlatteryCFOSell333,000$2.93$975,690.00440,974View SEC Filing  
10/18/2017Todd PopeInsiderSell600,000$3.68$2,208,000.00462,644View SEC Filing  
8/8/2017Willam N KelleyDirectorBuy30,000$0.71$21,300.00View SEC Filing  
5/16/2017Richard C Pfenniger JrDirectorBuy100,000$0.54$54,000.00148,000View SEC Filing  
1/4/2017S.P.A SofarMajor ShareholderBuy3,722,685$1.40$5,211,759.0019,266,098View SEC Filing  
8/22/2016Andrea BiffiDirectorBuy40,000$1.40$56,000.0090,000View SEC Filing  
6/14/2016Anthony C J FernandoCTOBuy27,000$1.46$39,420.0027,000View SEC Filing  
5/13/2016Joseph P SlatteryCFOBuy50,000$1.92$96,000.00172,387View SEC Filing  
11/16/2015Andrea BiffiDirectorBuy25,000$2.81$70,250.0050,000View SEC Filing  
11/13/2015Willam N KelleyDirectorBuy20,000$2.80$56,000.00View SEC Filing  
11/12/2015Joseph P SlatteryCFOBuy15,000$2.77$41,550.00135,087View SEC Filing  
10/2/2014Joseph P SlatteryCFOSell33,000$4.19$138,270.00View SEC Filing  
9/8/2014Richard MuellerCOOSell3,000$3.60$10,800.00View SEC Filing  
9/8/2014Todd PopeCEOSell50,000$3.70$185,000.00View SEC Filing  
4/21/2014Aisling Capital Iii LpMajor ShareholderBuy1,037,767$4.00$4,151,068.00View SEC Filing  
4/21/2014William N Starling JrDirectorBuy221,450$4.00$885,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Transenterix (NYSEAMERICAN TRXC) News Headlines

Source:
DateHeadline
TransEnterix Announces FDA 510(k) Submission for Senhance Indication Expansion to More than Double Addressable Market in the U.S. and Provides Commercial UpdateTransEnterix Announces FDA 510(k) Submission for Senhance Indication Expansion to More than Double Addressable Market in the U.S. and Provides Commercial Update
finance.yahoo.com - February 14 at 8:49 AM
Transenterix Inc (TRXC) Short Interest UpdateTransenterix Inc (TRXC) Short Interest Update
www.americanbankingnews.com - February 9 at 8:28 PM
TransEnterix to Present at the RBC Capital Markets 2018 Global Healthcare ConferenceTransEnterix to Present at the RBC Capital Markets 2018 Global Healthcare Conference
finance.yahoo.com - February 7 at 8:31 AM
TransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare ConferenceTransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - January 31 at 8:43 AM
This Mornings Technical Outlook on Medical Supplies Stocks -- TransEnterix, Akers Biosciences, Antares Pharma, and Microbot MedicalThis Morning's Technical Outlook on Medical Supplies Stocks -- TransEnterix, Akers Biosciences, Antares Pharma, and Microbot Medical
www.prnewswire.com - January 30 at 8:32 AM
Short Interest in Transenterix Inc (TRXC) Increases By 6.4%Short Interest in Transenterix Inc (TRXC) Increases By 6.4%
www.americanbankingnews.com - January 24 at 5:40 PM
Transenterix (TRXC) Rating Increased to Hold at Zacks Investment ResearchTransenterix (TRXC) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - January 23 at 6:08 PM
Edited Transcript of TRXC earnings conference call or presentation 10-May-17 8:30pm GMTEdited Transcript of TRXC earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - January 18 at 3:33 PM
Transenterix Inc (TRXC) Given Average Recommendation of "Hold" by BrokeragesTransenterix Inc (TRXC) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 13 at 4:01 AM
Transenterix (TRXC) Downgraded by Zacks Investment Research to SellTransenterix (TRXC) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - January 11 at 3:32 PM
Transenterix Inc (TRXC) Sees Large Increase in Short InterestTransenterix Inc (TRXC) Sees Large Increase in Short Interest
www.americanbankingnews.com - January 10 at 6:04 PM
Here's Why TransEnterix Rallied 47% in 2017Here's Why TransEnterix Rallied 47% in 2017
finance.yahoo.com - January 9 at 4:11 PM
TransEnterix (TRXC) Announces 2017 Year-End Corporate Update - StreetInsider.comTransEnterix (TRXC) Announces 2017 Year-End Corporate Update - StreetInsider.com
www.streetinsider.com - January 8 at 3:36 PM
TransEnterix's Piggy Bank Gets Fatter, but Are Shares Finally a Buy?TransEnterix's Piggy Bank Gets Fatter, but Are Shares Finally a Buy?
finance.yahoo.com - December 31 at 8:56 AM
Transenterix Inc (TRXC) Sees Significant Decrease in Short InterestTransenterix Inc (TRXC) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - December 28 at 2:09 AM
Transenterix Inc (TRXC) Given Average Rating of "Hold" by AnalystsTransenterix Inc (TRXC) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - December 19 at 3:52 PM
Transenterix (TRXC) Earns "Hold" Rating from BTIG ResearchTransenterix (TRXC) Earns "Hold" Rating from BTIG Research
www.americanbankingnews.com - December 19 at 1:18 PM
TransEnterix & GBIL Ink Deal to Commercialize SurgiBot SystemTransEnterix & GBIL Ink Deal to Commercialize SurgiBot System
finance.yahoo.com - December 19 at 10:47 AM
ETFs with exposure to TransEnterix, Inc. : December 18, 2017ETFs with exposure to TransEnterix, Inc. : December 18, 2017
finance.yahoo.com - December 18 at 5:45 PM
This News Caused TransEnterix's Stock to SpikeThis News Caused TransEnterix's Stock to Spike
finance.yahoo.com - December 18 at 3:30 PM
TransEnterix (TRXC) Enters Global SurgiBot System Agreement with GBILTransEnterix (TRXC) Enters Global SurgiBot System Agreement with GBIL
www.streetinsider.com - December 18 at 11:12 AM
Transenterix Inc (TRXC) Unleashes Deal to Commercialize SurgiBot SystemTransenterix Inc (TRXC) Unleashes Deal to Commercialize SurgiBot System
finance.yahoo.com - December 18 at 11:12 AM
TransEnterix announces global SurgiBot System agreement; shares ahead 13% premarket - Seeking AlphaTransEnterix announces global SurgiBot System agreement; shares ahead 13% premarket - Seeking Alpha
seekingalpha.com - December 18 at 9:12 AM
Transenterix Inc (TRXC) Short Interest Up 7.4% in NovemberTransenterix Inc (TRXC) Short Interest Up 7.4% in November
www.americanbankingnews.com - December 11 at 8:36 PM
7 ‘Strong Buy’ Disruptive Stocks You Should Track Now7 ‘Strong Buy’ Disruptive Stocks You Should Track Now
finance.yahoo.com - December 8 at 3:30 PM
ETFs with exposure to TransEnterix, Inc. : December 8, 2017ETFs with exposure to TransEnterix, Inc. : December 8, 2017
finance.yahoo.com - December 8 at 3:30 PM
Heres Why TransEnterix Inc. Stock Tanked 22% in DecemberHere's Why TransEnterix Inc. Stock Tanked 22% in December
www.fool.com - December 7 at 4:22 PM
Here's Why TransEnterix Inc. Stock Tanked 22% in DecemberHere's Why TransEnterix Inc. Stock Tanked 22% in December
finance.yahoo.com - December 7 at 3:35 PM
TransEnterix, Senhance Marketing Underway, Expanded Indications Planned for Early 2018TransEnterix, Senhance Marketing Underway, Expanded Indications Planned for Early 2018
finance.yahoo.com - December 7 at 9:05 AM
35 Stocks Moving In Wednesdays Pre-Market Session35 Stocks Moving In Wednesday's Pre-Market Session
feeds.benzinga.com - November 29 at 8:23 AM
ETFs with exposure to TransEnterix, Inc. : November 27, 2017ETFs with exposure to TransEnterix, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 8:31 AM
Transenterix Undisclosed Related Party Transactions - Seeking Alpha - Seeking AlphaTransenterix Undisclosed Related Party Transactions - Seeking Alpha - Seeking Alpha
seekingalpha.com - November 27 at 3:20 PM
Edited Transcript of TRXC earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of TRXC earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 20 at 11:25 AM
Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 Shares
www.americanbankingnews.com - November 16 at 10:36 PM
Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 Shares
www.americanbankingnews.com - November 16 at 10:33 PM

SEC Filings

Transenterix (NYSEAMERICAN:TRXC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Transenterix (NYSEAMERICAN:TRXC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Transenterix (NYSEAMERICAN TRXC) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.